Leaps by Bayer Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 14

Professionals

  • Investments
  • 127

  • Portfolio
  • 55

  • Exits
  • 27

Exits

Leaps by Bayer General Information

Company Description

Founded in 2015, Leaps by Bayer is the corporate venture capital arm of Bayer and is based in Leverkusen, Germany. The firm prefers to invest in the healthcare and agriculture.

Business Details

Website
leaps.bayer.com
Formerly Known As
Monsanto Growth Ventures
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Impact Investing
Corporate Office
  • Kaiser-Wilhelm-Allee 1
  • 51373 Leverkusen
  • Germany
+49 0214 000

Leaps by Bayer Investments (127)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Egenesis 04-Sep-2024 Later Stage VC 00000 Biotechnology Pre-Clinical Trials 00000 000000
GRO Biosciences 19-Jul-2024 00000 00000 000.00 Biotechnology Generating Revenue 000000000 00
Rantizo 19-Jun-2024 00000 00000 000.00 Other Hardware Generating Revenue 000000 00000
Bloom Science 18-Jun-2024 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
Summer Health 23-Apr-2024 00000 00000 000.00 Clinics/Outpatient Services Generating Revenue
Capstan Therapeutics 20-Mar-2024 00000 00000 00000 Biotechnology Pre-Clinical Trials 00000 00000
Atomwise 08-Mar-2024 00000 00000 Drug Discovery Generating Revenue
Transcarent 06-Mar-2024 00000 00000 00000 Other Healthcare Technology Systems Generating Revenue
9am.Health 20-Feb-2024 Early Stage VC 00.00 Other Healthcare Services Generating Revenue
NextPoint 14-Feb-2024 Early Stage VC 00000 Drug Discovery Generating Revenue 000000000 00
You’re viewing 10 of 127 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leaps by Bayer Exits (27)

Company Name Exit Date Exit Type Exit Size
AgBiome 11-Apr-2024 Merger/Acquisition
Boundless Bio 28-Mar-2024 000 00000
Metagenomi 09-Feb-2024 000 000.00
Resson Aerospace 20-Sep-2023 000 00 00000
Unfold (Horticulture) 11-Sep-2023 000000000000
Azitra 15-Jun-2023 000 00.00
Combyne (Media and Information Services B2B) 23-Jan-2023 000000000000
Joyn Bio 18-Oct-2022 000000000000
CoverCress 01-Aug-2022 Merger/Acquisition
Senti Bio 08-Jun-2022 Reverse Merger 00000
You’re viewing 10 of 27 exits. Get the full list »

Leaps by Bayer Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Leaps by Bayer Management, Team & Partners (22)

Name Title Deals Funds Boards Office
Kira Peikoff Deputy Director Communications Leverkusen, Germany
Karyn Riegel Deputy Director of Brand & Community Engagement Leverkusen, Germany
Denise Boehme Director of Portfolio Strategy & Reporting Leverkusen, Germany
Pei Sze Ng Director of Venture Investments 0 0 Leverkusen, Germany
Alev Oezmen Executive, Portfolio Strategy & Reporting Support Leverkusen, Germany
You’re viewing 5 of 22 team members. Get the full list »

Leaps by Bayer FAQs

  • What is Leaps by Bayer?

    Founded in 2015, Leaps by Bayer is the corporate venture capital arm of Bayer and is based in Leverkusen, Germany.

  • When was Leaps by Bayer founded?

    Leaps by Bayer was founded in 2015.

  • Where is Leaps by Bayer headquartered?

    Leaps by Bayer is headquartered in Leverkusen, Germany.

  • How many investments has Leaps by Bayer made?

    Leaps by Bayer has made 127 investments.

  • What has Leaps by Bayer invested in?

    Leaps by Bayer has made numerous investments in companies like Egenesis, GRO Biosciences, and Rantizo within the Biotechnology and Hardware industries.

  • What has Leaps by Bayer invested in recently?

    Leaps by Bayer's latest investment was on 04-Sep-2024 in Egenesis, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »